NIPPA ASSOCIATES LIMITED
Company number 13059635 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
NIPPA ASSOCIATES LIMITED - Analysis Report
Company Number: 13059635
Analysis Date: 2025-07-29 18:03 UTC
Financial Health Assessment: NIPPA ASSOCIATES LIMITED (As of 31 December 2023)
1. Financial Health Score: D
Explanation:
The company shows signs of financial distress with negative shareholder funds (equity), indicating it is technically insolvent on a balance sheet basis. While it maintains current assets above £161k, current liabilities and long-term creditors combined outweigh assets, resulting in negative net worth. The company's ability to sustain operations without additional funding or restructuring is questionable, warranting a below-average health score.
2. Key Vital Signs
| Metric | 2023 Value | Interpretation |
|---|---|---|
| Fixed Assets | £1,026 | Minimal investment in long-term assets; typical for a micro entity but limits collateral value. |
| Current Assets | £161,422 | Cash, receivables, or inventory available within a year; a healthy level for working capital. |
| Current Liabilities | £34,009 | Debts due within one year; manageable relative to current assets, indicating short-term liquidity. |
| Creditors (Long-term) | £173,166 | Significant long-term liabilities; a heavy burden impacting solvency and financial stability. |
| Net Current Assets | £127,413 | (Current Assets - Current Liabilities); positive, indicating good short-term liquidity. |
| Shareholders’ Funds (Equity) | -£39,076 | Negative net worth; liabilities exceed assets, indicating insolvency on a balance sheet basis. |
| Share Capital | £1.00 | Nominal share capital; does not contribute meaningfully to financial strength. |
| Employees | 0 | No employees; possibly a dormant or asset-holding structure rather than an operational business. |
3. Diagnosis: Financial Symptoms and Underlying Health
Healthy Cash Flow vs. Capital Structure:
The company shows a healthy short-term liquidity position with net current assets at £127k, suggesting it can meet immediate obligations (no short-term distress). However, this positive liquidity "pulse" is overshadowed by substantial long-term creditors (£173k), creating a chronic "disease" of negative net assets.Negative Equity – Symptom of Financial Distress:
Negative shareholders’ funds of -£39,076 indicate the company owes more than it owns. This is akin to a patient with vital organs (assets) failing to support the body's needs (liabilities). While not necessarily insolvent in cash terms due to positive working capital, this condition signals potential solvency issues if liabilities fall due or if creditors demand repayment.No Employees and Minimal Fixed Assets:
The absence of employees and minimal fixed assets suggest the company may be a holding or project vehicle rather than an active business with ongoing operations. This may limit revenue-generating capacity and increase dependency on external funding or creditor patience.Growing Long-term Creditors:
The increase in long-term liabilities from £124k in 2022 to £173k in 2023 indicates rising debt burden, possibly from loans or deferred payments. Without corresponding asset growth or profitability, this trend worsens the prognosis.No Audit, Micro Entity Reporting:
The financial statements are prepared under micro-entity provisions and unaudited, which limits the depth of financial scrutiny. This may conceal some financial risks or operational challenges.
4. Prognosis: Future Financial Outlook
Given the current financial indicators, the prognosis is cautious to unfavorable without intervention. The company’s short-term liquidity is stable, but its negative equity and high long-term liabilities pose risks of insolvency or creditor enforcement. Without improvement in profitability, capital injection, or debt restructuring, the company may face increasing financial pressure.
5. Recommendations: Prescriptions for Financial Wellness
Debt Restructuring:
Engage with creditors to renegotiate terms of long-term liabilities to reduce immediate pressure and avoid default. Consider extending repayment periods or converting debt to equity if possible.Capital Injection:
The director or shareholders should consider injecting additional capital to restore positive equity and improve solvency, akin to administering a life-saving treatment.Operational Review:
If the company is intended to operate actively, initiate business development to generate revenue and profits. If it is a holding entity, assess the purpose of liabilities and whether asset sales or refinancing can alleviate debt.Cash Flow Monitoring:
Maintain vigilant monitoring of cash flows to ensure the company remains capable of meeting short-term obligations, preventing liquidity crises.Professional Advice:
Consult insolvency or financial restructuring professionals to explore turnaround strategies before financial distress escalates.
Executive Summary
Sign in to generate a free AI analysis of this company — no password needed, just an email link.